Back to search

United Kingdom· GB-APID-35778311000001108

Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials

A cytarabine and daunorubicin product containing daunorubicin + cytarabine, registered in United Kingdom by Jazz Pharmaceuticals UK Ltd. The same ATC class is registered in 13 of our 19 countries.

ATC L01XY01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedVyxeos liposomal 44mg/100mg powder fo…ATCL01XY01REGISTER NO.GB-APID-3577831100000…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Cytarabine and daunorubicin is registered in 13 of 19 countries.

Countries holding a registration under ATC L01XY01 (cytarabine and daunorubicin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Cytarabine and daunorubicin · ATC L01XY01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Daunorubicin + Cytarabine
Manufacturer
Jazz Pharmaceuticals UK Ltd
Country
United Kingdom (GB)
ATC code
L01XY01
ATC class
Cytarabine and daunorubicin
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e7a44c19-4ed9-40a7-b2aa-376957693d6e
GET /v1/drugs/e7a44c19-4ed9-40a7-b2aa-376957693d6e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "35778311000001108",
  "desc": "Vyxeos liposomal 44mg/100mg powder for concentrate for solution for infusion vials (Jazz Pharmaceuticals UK Ltd)",
  "form": "Powder for solution for infusion",
  "vpid": "35812911000001103",
  "source": "dmd",
  "vtm_id": "1290601005",
  "strength": "44 mg",
  "substance": "Daunorubicin + Cytarabine",
  "ingredient": "Daunorubicin",
  "supplier_code": "34938211000001101"
}

See everything about cytarabine and daunorubicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.